Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4-Reference-Cited by-同舟云学术

Biological Landscape of Triple Negative Breast Cancers Expressing CTLA-4

Published:2020-08-05 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Navarrete-Bernal María G. C.,Cervantes-Badillo Mayte G.,Martínez-Herrera Jose Fabián,Lara-Torres César O.,Gerson-Cwilich Raquel,Zentella-Dehesa Alejandro,Ibarra-Sánchez María de Jesús,Esparza-López José,Montesinos Juan J.,Cortés-Morales Víctor Adrián,Osorio-Pérez Diego,Villegas-Osorno Diana A.,Reyes-Sánchez Eduardo,Salazar-Sojo Pablo,Tallabs-Utrilla Luis F.,Romero-Córdoba Sandra,Rocha-Zavaleta Leticia

Funder

Universidad Nacional Autónoma de México

Consejo Nacional de Ciencia y Tecnología

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference87 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018

2. Therapies for triple negative breast cancer;Andreopoulou;Expert Opin Pharmacother.,2015

3. Clinical and epidemiological profile of breast cancer in Mexico: results of the seguro popular;Reynoso-Noveron;J Glob Oncol.,2017

4. Triple-negative breast cancers are increased in black women regardless of age or body mass index;Stead;Breast Cancer Res.,2009

5. Advances in the systemic treatment of triple-negative breast cancer;Lebert;Curr Oncol.,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mimicking the immunosuppressive impact of fibroblasts in a 3D multicellular spheroid model;Frontiers in Drug Discovery;2024-07-26

2. Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer;European Journal of Medical Research;2024-07-02

3. Expression of Immune Checkpoint Regulator Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death Protein Ligand 1 (PD-L1) in Invasive Ductal Carcinoma Breast;Indian Journal of Surgical Oncology;2024-06-13

4. High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype;2024-01-31

5. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer;Journal of Translational Medicine;2023-10-14